Declining rates of treatment-related mortality in patients with newly diagnosed AML given ‘intense’ induction regimens: a report from SWOG and MD Anderson
Othus, M, Kantarjian, H, Petersdorf, S, Ravandi, F, Godwin, J, Cortes, J, Pierce, S, Erba, H, Faderl, S, Appelbaum, F R, Estey, E
Published in Leukemia (01.02.2014)
Published in Leukemia (01.02.2014)
Get full text
Journal Article
A prognostic score for patients with lower risk myelodysplastic syndrome
Garcia-Manero, G, Shan, J, Faderl, S, Cortes, J, Ravandi, F, Borthakur, G, Wierda, W G, Pierce, S, Estey, E, Liu, J, Huang, X, Kantarjian, H
Published in Leukemia (01.03.2008)
Published in Leukemia (01.03.2008)
Get full text
Journal Article
Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation
Chen, Y, Kantarjian, H, Pierce, S, Faderl, S, O'Brien, S, Qiao, W, Abruzzo, L, de Lima, M, Kebriaei, P, Jabbour, E, Daver, N, Kadia, T, Estrov, Z, Garcia-Manero, G, Cortes, J, Ravandi, F
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
Final report of phase II study of sorafenib, cytarabine and idarubicin for initial therapy in younger patients with acute myeloid leukemia
Ravandi, F, Arana Yi, C, Cortes, J E, Levis, M, Faderl, S, Garcia-Manero, G, Jabbour, E, Konopleva, M, O'Brien, S, Estrov, Z, Borthakur, G, Thomas, D, Pierce, S, Brandt, M, Pratz, K, Luthra, R, Andreeff, M, Kantarjian, H
Published in Leukemia (01.07.2014)
Published in Leukemia (01.07.2014)
Get full text
Journal Article
The combination of hyper-CVAD plus nelarabine as frontline therapy in adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma: MD Anderson Cancer Center experience
Jain, P, Kantarjian, H, Ravandi, F, Thomas, D, O'Brien, S, Kadia, T, Burger, J, Borthakur, G, Daver, N, Jabbour, E, Konopleva, M, Cortes, J, Pemmaraju, N, Kelly, M A, Cardenas-Turanzas, M, Garris, R, Faderl, S
Published in Leukemia (01.04.2014)
Published in Leukemia (01.04.2014)
Get full text
Journal Article
Dynamic acquisition of FLT3 or RAS alterations drive a subset of patients with lower risk MDS to secondary AML
Takahashi, K, Jabbour, E, Wang, X, Luthra, R, Bueso-Ramos, C, Patel, K, Pierce, S, Yang, H, Wei, Y, Daver, N, Faderl, S, Ravandi, F, Estrov, Z, Cortes, J, Kantarjian, H, Garcia-Manero, G
Published in Leukemia (01.10.2013)
Published in Leukemia (01.10.2013)
Get full text
Journal Article
The JAK-STAT pathway: a therapeutic target in hematological malignancies
Ferrajoli, A, Faderl, S, Ravandi, F, Estrov, Z
Published in Current cancer drug targets (01.12.2006)
Published in Current cancer drug targets (01.12.2006)
Get more information
Journal Article
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution
Santos, F P S, Faderl, S, Garcia-Manero, G, Koller, C, Beran, M, O'Brien, S, Pierce, S, Freireich, E J, Huang, X, Borthakur, G, Bueso-Ramos, C, de Lima, M, Keating, M, Cortes, J, Kantarjian, H, Ravandi, F
Published in Leukemia (01.12.2009)
Published in Leukemia (01.12.2009)
Get full text
Journal Article
A randomized study of decitabine versus conventional care for maintenance therapy in patients with acute myeloid leukemia in complete remission
Boumber, Y, Kantarjian, H, Jorgensen, J, Wen, S, Faderl, S, Castoro, R, Autry, J, Garcia-Manero, G, Borthakur, G, Jabbour, E, Estrov, Z, Cortes, J, Issa, J-P, Ravandi, F
Published in Leukemia (01.11.2012)
Published in Leukemia (01.11.2012)
Get full text
Journal Article
Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia
Kantarjian, Hagop, Gandhi, Varsha, Cortes, Jorge, Verstovsek, Srdan, Du, Min, Garcia-Manero, Guillermo, Giles, Francis, Faderl, Stefan, O’Brien, Susan, Jeha, Sima, Davis, Jan, Shaked, Zeev, Craig, Adam, Keating, Michael, Plunkett, William, Freireich, Emil J
Published in Blood (01.10.2003)
Published in Blood (01.10.2003)
Get full text
Journal Article
Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome
Tambaro, F P, Garcia-Manero, G, O'Brien, S M, Faderl, S H, Ferrajoli, A, Burger, J A, Pierce, S, Wang, X, Do, K-A, Kantarjian, H M, Keating, M J, Wierda, W G
Published in Leukemia (01.02.2016)
Published in Leukemia (01.02.2016)
Get full text
Journal Article
Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome
De Padua Silva, L, de Lima, M, Kantarjian, H, Faderl, S, Kebriaei, P, Giralt, S, Davisson, J, Garcia-Manero, G, Champlin, R, Issa, J-P, Ravandi, F
Published in Bone marrow transplantation (Basingstoke) (01.06.2009)
Published in Bone marrow transplantation (Basingstoke) (01.06.2009)
Get full text
Journal Article
P515: LOWER‐INTENSITY CPX‐351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY
Uy, G. L., Pullarkat, V. A., Baratam, P., Stuart, R. K., Walter, R. B., Winer, E. S., Faderl, S., Chandrasekaran, V., Wang, Q., Chakravarthy, D., Cheung, R. S., Lin, T. L.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P514: V‐FAST MASTER TRIAL: PRELIMINARY RESULTS OF TREATMENT WITH CPX‐351 PLUS MIDOSTAURIN IN ADULTS WITH NEWLY DIAGNOSED FLT3‐MUTATED ACUTE MYELOID LEUKEMIA
McCloskey, J., Pullarkat, V., Mannis, G., Lin, T. L., Strickland, S. A., Fathi, A. T., Erba, H. P., Faderl, S., Chakravarthy, D., Lutska, Y., Chandrasekaran, V., Cheung, R. S., Levis, M.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
FIVE-YEAR FINAL RESULTS OF A PHASE 3 STUDY OF CPX-351 VERSUS 7+3 IN OLDER ADULTS WITH NEWLY DIAGNOSED HIGH-RISK/SECONDARY ACUTE MYELOID LEUKEMIA (AML)
Lancet, J.E., Lin, T.L., Hogge, D., Solomon, S.R., Schiller, G.J., Wieduwilt, M.J., Martin, R., Faderl, S., Chang, Y., Cortes, J.E.
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Published in Hematology, Transfusion and Cell Therapy (01.11.2020)
Get full text
Journal Article
Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia
Kantarjian, H. M., Padmanabhan, S., Stock, W., Tallman, M. S., Curt, G. A., Li, J., Osmukhina, A., Wu, K., Huszar, D., Borthukar, G., Faderl, S., Garcia-Manero, G., Kadia, T., Sankhala, K., Odenike, O., Altman, J. K., Minden, M.
Published in Investigational new drugs (01.06.2012)
Published in Investigational new drugs (01.06.2012)
Get full text
Journal Article
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy
Tam, Constantine S., O'Brien, Susan, Lerner, Susan, Khouri, I., Ferrajoli, A., Faderl, S., Browning, M., Tsimberidou, Apostolia M., Kantarjian, Hagop, Wierda, William G.
Published in Leukemia & lymphoma (01.01.2007)
Published in Leukemia & lymphoma (01.01.2007)
Get full text
Journal Article
Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome
Garg, R, Faderl, S, Garcia-Manero, G, Cortes, J, Koller, C, Huang, X, York, S, Pierce, S, Brandt, M, Beran, M, Borthakur, G, Kantarjian, H, Ravandi, F
Published in Leukemia (01.07.2009)
Published in Leukemia (01.07.2009)
Get full text
Journal Article
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy
TSIMBERIDOU, A-M, KANTARJIAN, H. M, KEATING, M. J, BITAR, M. A, O'BRIEN, S, GILES, F. J, ESTEY, E, CORTES, J. E, VERSTOVSEK, S, FADERL, S, THOMAS, D. A, GARCIA-MANERO, G, FERRAJOLI, A, MANNING, J. T
Published in Leukemia (01.06.2003)
Published in Leukemia (01.06.2003)
Get full text
Journal Article